Three candidate genes, KLF9, KLF10 and ZNF165, were randomly selected for validation by using a real-time PCR analysis in the 6 additional explanted COPD lungs from GOLD IV cases with and without ZZ AATD. The gene discussed is KLF10; the disease is alpha 1-antitrypsin deficiency.